Literature DB >> 21955986

Characterization of a new ARID family transcription factor (Brightlike/ARID3C) that co-activates Bright/ARID3A-mediated immunoglobulin gene transcription.

Josephine A Tidwell1, Christian Schmidt, Phillip Heaton, Van Wilson, Philip W Tucker.   

Abstract

Two members, Bright/ARID3A and Bdp/ARID3B, of the ARID (AT-Rich Interaction Domain) transcription family are distinguished by their ability to specifically bind to DNA and to self-associate via a second domain, REKLES. Bright and Bdp positively regulate immunoglobulin heavy chain gene (IgH) transcription by binding to AT-rich motifs within Matrix Associating Regions (MARs) residing within a subset of V(H) promoters and the Eμ intronic enhancer. In addition, REKLES provides Bright nuclear export function, and a small pool of Bright is directed to plasma membrane sub-domains/lipid rafts where it associates with and modulates signaling of the B cell antigen receptor (BCR). Here, we characterize a third, highly conserved, physically condensed ARID3 locus, Brightlike/ARID3C. Brightlike encodes two alternatively spliced, SUMO-I-modified isoforms that include or exclude (Δ6) the REKLES-encoding exon 6. Brightlike transcripts and proteins are expressed preferentially within B lineage lymphocytes and coordinate with highest Bright expression in activated follicular B cells. Brightlike, but not BrightlikeΔ6, undergoes nuclear-cytoplasmic shuttling with a fraction localizing within lipid rafts following BCR stimulation. Brightlike, but not BrightlikeΔ6, associates with Bright in solution, at common DNA binding sites in vitro, and is enriched at Bright binding sites in chromatin. Although possessing little transactivation capacity of its own, Brightlike significantly co-activates Bright-dependent IgH transcription with maximal activity mediated by the unsumoylated form. In sum, this report introduces Brightlike as an additional functional member of the family of ARID proteins, which should be considered in regulatory circuits, previously ascribed to be mediated by Bright.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21955986      PMCID: PMC3205283          DOI: 10.1016/j.molimm.2011.08.025

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  35 in total

1.  Transcriptional activation by a matrix associating region-binding protein. contextual requirements for the function of bright.

Authors:  M H Kaplan; R T Zong; R F Herrscher; R H Scheuermann; P W Tucker
Journal:  J Biol Chem       Date:  2001-04-06       Impact factor: 5.157

Review 2.  ARID proteins come in from the desert.

Authors:  R D Kortschak; P W Tucker; R Saint
Journal:  Trends Biochem Sci       Date:  2000-06       Impact factor: 13.807

3.  B-cell and plasma-cell splicing differences: a potential role in regulated immunoglobulin RNA processing.

Authors:  Shirley R Bruce; R W Cameron Dingle; Martha L Peterson
Journal:  RNA       Date:  2003-10       Impact factor: 4.942

4.  The ARID family transcription factor bright is required for both hematopoietic stem cell and B lineage development.

Authors:  Carol F Webb; James Bryant; Melissa Popowski; Laura Allred; Dongkoon Kim; June Harriss; Christian Schmidt; Cathrine A Miner; Kira Rose; Hwei-Ling Cheng; Courtney Griffin; Philip W Tucker
Journal:  Mol Cell Biol       Date:  2011-01-03       Impact factor: 4.272

5.  Bovine papillomavirus E1 protein is sumoylated by the host cell Ubc9 protein.

Authors:  D Rangasamy; V G Wilson
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

Review 6.  Polycomb-group genes as regulators of mammalian lymphopoiesis.

Authors:  F M Raaphorst; A P Otte; C J Meijer
Journal:  Trends Immunol       Date:  2001-12       Impact factor: 16.687

7.  The structure of the Dead ringer-DNA complex reveals how AT-rich interaction domains (ARIDs) recognize DNA.

Authors:  Junji Iwahara; Mizuho Iwahara; Gary W Daughdrill; Joseph Ford; Robert T Clubb
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

8.  The transcription factor Bright associates with Bruton's tyrosine kinase, the defective protein in immunodeficiency disease.

Authors:  C F Webb; Y Yamashita; N Ayers; S Evetts; Y Paulin; M E Conley; E A Smith
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

Review 9.  A significant fraction of conserved noncoding DNA in human and mouse consists of predicted matrix attachment regions.

Authors:  Galina V Glazko; Eugene V Koonin; Igor B Rogozin; Svetlana A Shabalina
Journal:  Trends Genet       Date:  2003-03       Impact factor: 11.639

10.  The B cell-specific major raft protein, Raftlin, is necessary for the integrity of lipid raft and BCR signal transduction.

Authors:  Kazuko Saeki; Yoshiki Miura; Daisuke Aki; Tomohiro Kurosaki; Akihiko Yoshimura
Journal:  EMBO J       Date:  2003-06-16       Impact factor: 11.598

View more
  12 in total

1.  Characterization of kiss2 and kissr2 genes and the regulation of kisspeptin on the HPG axis in Cynoglossus semilaevis.

Authors:  Huayu Song; Mengxun Wang; Zhongkai Wang; Jinxiang Liu; Jie Qi; Quanqi Zhang
Journal:  Fish Physiol Biochem       Date:  2016-12-24       Impact factor: 2.794

2.  ARID3A and ARID3B induce stem promoting pathways in ovarian cancer cells.

Authors:  Paige Dausinas; Kirthi Pulakanti; Sridhar Rao; Jennifer M Cole; Richard Dahl; Karen D Cowden Dahl
Journal:  Gene       Date:  2020-02-13       Impact factor: 3.688

3.  Protein tyrosine phosphatase receptor type R (PTPRR) antagonizes the Wnt signaling pathway in ovarian cancer by dephosphorylating and inactivating β-catenin.

Authors:  Yuetong Wang; Jian Cao; Weiwei Liu; Jiali Zhang; Zuo Wang; Yiqun Zhang; Linjun Hou; Shengmiao Chen; Piliang Hao; Liye Zhang; Min Zhuang; Yang Yu; Dake Li; Gaofeng Fan
Journal:  J Biol Chem       Date:  2019-10-25       Impact factor: 5.157

4.  Identification of Tumor Microenvironment-Related Prognostic Biomarkers for Ovarian Serous Cancer 3-Year Mortality Using Targeted Maximum Likelihood Estimation: A TCGA Data Mining Study.

Authors:  Lu Wang; Xiaoru Sun; Chuandi Jin; Yue Fan; Fuzhong Xue
Journal:  Front Genet       Date:  2021-06-03       Impact factor: 4.599

5.  Application of whole genome and RNA sequencing to investigate the genomic landscape of common variable immunodeficiency disorders.

Authors:  Pauline A van Schouwenburg; Emma E Davenport; Anne-Kathrin Kienzler; Ishita Marwah; Benjamin Wright; Mary Lucas; Tomas Malinauskas; Hilary C Martin; Helen E Lockstone; Jean-Baptiste Cazier; Helen M Chapel; Julian C Knight; Smita Y Patel
Journal:  Clin Immunol       Date:  2015-06-26       Impact factor: 3.969

6.  Expression Signature of the AT-Rich Interactive Domain Gene Family Identified in Digestive Cancer.

Authors:  Yongqu Lu; Zhenzhen Liu; Wendong Wang; Xin Chen; Xin Zhou; Wei Fu
Journal:  Front Med (Lausanne)       Date:  2022-01-20

7.  Comprehensive Landscape of ARID Family Members and Their Association with Prognosis and Tumor Microenvironment in Hepatocellular Carcinoma.

Authors:  Ji Sun; Nan-Sheng Cheng
Journal:  J Immunol Res       Date:  2022-03-30       Impact factor: 4.818

8.  ARID3B induces tumor necrosis factor alpha mediated apoptosis while a novel ARID3B splice form does not induce cell death.

Authors:  Stancy Joseph; Victoria E Deneke; Karen D Cowden Dahl
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

Review 9.  Recent advances in the ARID family: focusing on roles in human cancer.

Authors:  Chen Lin; Wei Song; Xinyu Bi; Jianjun Zhao; Zhen Huang; Zhiyu Li; Jianguo Zhou; Jianqiang Cai; Hong Zhao
Journal:  Onco Targets Ther       Date:  2014-02-18       Impact factor: 4.147

10.  Harnessing stemness and PD-L1 expression by AT-rich interaction domain-containing protein 3B in colorectal cancer.

Authors:  Tsai-Tsen Liao; Chun-Chi Lin; Jeng-Kae Jiang; Shung-Haur Yang; Hao-Wei Teng; Muh-Hwa Yang
Journal:  Theranostics       Date:  2020-05-15       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.